iShares Biotechnology ETF Stock Forecast, Price & News

iShares Biotechnology ETF's stock was trading at $152.62 at the beginning of the year. Since then, IBB stock has decreased by 23.3% and is now trading at $117.00.
View the best growth stocks for 2022 here.

iShares Biotechnology ETF declared a quarterly dividend on Wednesday, June 8th. Stockholders of record on Friday, June 10th will be given a dividend of $0.031 per share on Wednesday, June 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.11%. The ex-dividend date of this dividend is Thursday, June 9th.
View iShares Biotechnology ETF's dividend history.

iShares Biotechnology ETF(NASDAQ:IBB) pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.26%.
View iShares Biotechnology ETF's dividend history.

iShares Biotechnology ETF's stock split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly created shares were payable to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Biotechnology ETF stock prior to the split would have 300 shares after the split.

Some companies that are related to iShares Biotechnology ETF include iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), SPDR Dow Jones Industrial Average ETF Trust (DIA), iShares MSCI Emerging Markets ETF (EEM), Consumer Discretionary Select Sector SPDR Fund (XLY), SPDR Bloomberg High Yield Bond ETF (JNK), SPDR Nuveen Barclays Short Term Municipal Bond ETF (SHM), DNP Select Income Fund (DNP), SPDR Nuveen Barclays Municipal Bond ETF (TFI), iShares MSCI Pacific ex Japan ETF (EPP), Nuveen Municipal Value Fund (NUV), WisdomTree Emerging Markets High Dividend Fund (DEM), Goldman Sachs BDC (GSBD), Direxion Daily Financial Bull 3X Shares (FAS), iShares MSCI Australia ETF (EWA) and Adams Diversified Equity Fund (ADX).
View all of IBB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

iShares Biotechnology ETF's stock is owned by many different institutional and retail investors. Top institutional investors include Bank of America Corp DE (19.42%), UBS Group AG (3.10%), Citigroup Inc. (3.03%), Goldman Sachs Group Inc. (2.42%), Royal Bank of Canada (1.97%) and JPMorgan Chase & Co. (0.98%).

IBB stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Bank Julius Baer & Co. Ltd Zurich, Jane Street Group LLC, Alpha Cubed Investments LLC, Mmbg Investment Advisors CO., Cutler Group LP, Royal Bank of Canada, and Cetera Advisor Networks LLC.

IBB stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Goldman Sachs Group Inc., Citigroup Inc., Hackensack Meridian Health Inc., UBS Group AG, JPMorgan Chase & Co., Tredje AP fonden, and Atria Wealth Solutions Inc..

Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IBB stock can currently be purchased for approximately $117.00.

iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.57 billion.